We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




End-of-Life Choices Affected by Doctors' Outlook

By HospiMedica staff writers
Posted on 23 Sep 2004
A survey of 900 doctors has revealed that a doctor's level of comfort in discussing death and presenting options to terminally ill patients are affected by the doctor's medical ethics training and the doctor's religious affiliation.

Researchers surveyed 900 members of the Society of Gynecologic Oncologists, and the results were published in the September 2004 issue of the International Journal of Gynecological Cancer. More...
These doctors treat patients both surgically and medically, and they exercise significant influence in conversations between them and patients regarding life-sustaining decisions, affecting a patient's last days with family or hope from further treatments that may or may not be futile. Some of the key aspects of these conversations were noted as "straight talk” and "compassion.” However, 8% said they would avoid telling patients they have a terminal condition, and only 75% would disclose to patients with inoperable cervical cancer that their disease is incurable, prior to starting treatment.

"It is important to recognize opportunities to help physicians to speak about their concerns and to improve conversations about breaking bad news,” said study author Dr. Lois Ramondetta, assistant professor in the department of gynecologic oncology at the University of Texas M.D. Anderson Cancer Center (Houston, USA). A team approach involving nurses, clergy, doctors, and psychiatrists, educational workshops, and taped practice sessions were among those methods favored to help change current approaches and improve patient awareness and options.




Related Links:
M.D. Anderson Cancer Center

Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
ow Frequency Pulse Massager
ET10 L
Mammography System (Analog)
MAM VENUS
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.